Diabetes treatment also reduces heart failure risk
Type 2 diabetes treatment, dapagliflozin, is also effective for reducing the risk of heart failure, according to research presented at the European Society of Cardiology conference in Paris.Times
Source: Society for Endocrinology - Category: Endocrinology Source Type: news
More News: Cardiology | Conferences | Dapagliflozin | Diabetes | Diabetes Type 2 | Endocrinology | Forxiga | Heart | Heart Failure